• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    HMH Announces Fourth Quarter and Full Year 2021 Results

    2/24/22 7:00:00 AM ET
    $HMHC
    Service to the Health Industry
    Miscellaneous
    Get the next $HMHC alert in real time by email

    BOSTON, Feb. 24, 2022 /PRNewswire/ -- HMH (NASDAQ:HMHC), a learning technology company, announced financial results for the fourth quarter and full year ended December 31, 2021.

    (PRNewsfoto/Houghton Mifflin Harcourt)

    Q4 and Full Year 2021 Financial Results:





    Three Months Ended December 31,





    Years Ended December 31,



    (in millions of dollars)



    2021 1





    2020 1





    Change





    2021 1





    2020 1





    Change



    Net sales



    $

    179





    $

    141







    26.7

    %



    $

    1,051





    $

    840







    25.0

    %

    Change in deferred revenue





    (47)







    (48)







    (3.0)

    %





    59







    58







    2.1

    %

    Billings 2





    132







    93







    42.0

    %





    1,110







    899







    23.5

    %

    Impairment charge for goodwill





    —







    17





    NM







    —







    279





    NM



    (Loss) income from continuing operations





    (46)







    (88)







    47.4

    %





    2







    (471)





    NM



    Adjusted EBITDA 3





    24







    (7)





    NM







    270







    89





    NM



    Pre-publication or content development costs





    (14)







    (10)







    41.7

    %





    (56)







    (61)







    (7.7)

    %

    Net cash provided by operating activities





    71







    40







    75.7

    %





    264







    106





    NM



    Free cash flow 3





    47







    15





    NM







    168







    (5)





    NM



    ________________



    1

    All amounts exclude the impact of the HMH Books & Media business which has been removed from continuing operations and classified as discontinued operations since the first quarter of 2021.   

    2

    An operating measure. Please refer to "Operating Metrics" for an explanation.

    3

    A non-GAAP measure. Please refer to Use of Non-GAAP Financial Measures for an explanation and reconciliation. We are unable to reconcile forward looking unlevered free cash flow without unreasonable efforts.

    NM = not meaningful

    Additional information regarding Q4 and full year 2021 financial results will be included in the Company's Annual Report on Form 10-K.

    Conference Call:

    Given the recently announced agreement for HMH to be acquired by entities affiliated with The Veritas Capital Fund VII, L.P., the Company will not be hosting a conference call to discuss its financial results.

    Use of Non-GAAP Financial Measures:

    To supplement our financial statements presented in accordance with Generally Accepted Accounting Principles (GAAP) and to provide additional insights into our performance, we have presented adjusted EBITDA from continuing operations and free cash flow. These measures are not prepared in accordance with GAAP. This information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. Management believes that the presentation of these non-GAAP measures provides useful information to investors regarding our results of operations and/or our expected results of operations because it assists both investors and management in analyzing and benchmarking the performance and value of our business.

    Management believes that the presentation of adjusted EBITDA provides useful information to our investors and management as an indicator of our performance that is not affected by debt restructurings, fluctuations in interest rates or effective tax rates, gains or losses on investments, non-cash charges and impairment charges, levels of depreciation or amortization, and acquisition/disposition-related activity costs, legal settlement costs, restructuring costs and integration costs. Accordingly, management believes that this measure is useful for comparing our performance from period to period and makes decisions based on it. In addition, targets in adjusted EBITDA (further adjusted to include the change in deferred revenue) are used as performance measures to determine certain incentive compensation of management. Management also believes that the presentation of free cash flow provides useful information to our investors because management regularly reviews these metrics as an important indicator of how much cash is generated by general business operations, excluding capital expenditures, and makes decisions based on it.

    Other companies may define these non-GAAP measures differently and, as a result, our use of these non-GAAP measures may not be directly comparable to adjusted EBITDA and free cash flow used by other companies. Although we use these non-GAAP measures as financial measures to assess our business, the use of non-GAAP measures is limited as they include and/or do not include certain items not included and/or included in the most directly comparable GAAP measure. Adjusted EBITDA should be considered in addition to, and not as a substitute for, net income or loss prepared in accordance with GAAP as a measure of performance; and free cash flow should be considered in addition to, and not as a substitute for, net cash from operating activities prepared in accordance with GAAP. Adjusted EBITDA is not intended to be a measure of liquidity nor is free cash flow intended to be a measure of residual cash flow available for discretionary use. You are cautioned not to place undue reliance on these non-GAAP measures. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures and related disclosure is provided in the appendix to this news release.

    Operating Metrics:

    Billings is an operating measure which we derive from net sales taking into account the change in deferred revenue. Billings for Core Solutions and Extensions is an operating measure based on invoiced sales adjusted for returns, other publishing income and change in deferred revenue.

    About Houghton Mifflin Harcourt

    Houghton Mifflin Harcourt (NASDAQ:HMHC) is a learning technology company committed to delivering connected solutions that engage learners, empower educators and improve student outcomes. As a leading provider of K–12 core curriculum, supplemental and intervention solutions, and professional learning services, HMH partners with educators and school districts to uncover solutions that unlock students' potential and extend teachers' capabilities. HMH serves more than 50 million students and 3 million educators in 150 countries. For more information, visit www.hmhco.com

    Follow HMH on Twitter, Facebook, Instagram and YouTube.

    Contact

    Investor Relations

    Chris Symanoskie, IRC

    VP, Investor Relations

    410-215-1405

    [email protected]

    Media Relations

    Bianca Olson

    SVP, Corporate Affairs

    617-351-3841

    [email protected]

    Important Information

    On February 22, 2022, HMH announced that it has entered into a definitive merger agreement with certain affiliates of Veritas Capital, a leading private equity investment firm, for the acquisition of the Company via a tender offer. The tender offer for the outstanding shares of HMH common stock has not yet commenced. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares of HMH common stock. The solicitation and offer to buy shares of HMH common stock will only be made pursuant to the tender offer materials that Veritas intends to file with the U.S. Securities and Exchange Commission (the "SEC"). At the time the tender offer is commenced, Veritas will file a tender offer statement on Schedule TO with the SEC, and HMH will file a solicitation/recommendation statement on Schedule 14D-9 with respect to the tender offer. HMH's STOCKHOLDERS ARE ADVISED TO READ THE SCHEDULE TO (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS) AND THE SCHEDULE 14D-9, AS EACH MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BEFORE THEY MAKE ANY DECISION WITH RESPECT TO THE TENDER OFFER BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES THERETO. Both the tender offer statement and the solicitation/recommendation statement will be mailed to HMH's stockholders free of charge. Investors and stockholders may obtain free copies of the Schedule TO and Schedule 14D-9, as each may be amended or supplemented from time to time, and other documents filed by the parties (when available) at the SEC's web site at www.sec.gov, by contacting HMH's Investor Relations either by telephone at 410-215-1405 or e-mail at [email protected] or on HMH's website at www.hmhco.com.

     

     

    Houghton Mifflin Harcourt Company

    Consolidated Balance Sheets







    December 31,



    (in thousands of dollars, except share information)



    2021





    2020



    Assets

















    Current assets

















    Cash and cash equivalents



    $

    463,131





    $

    281,200



    Accounts receivable, net of allowances





    135,495







    88,830



    Inventories





    117,469







    145,553



    Prepaid expenses and other assets





    43,339







    19,276



    Assets of discontinued operations





    —







    160,053



    Total current assets





    759,434







    694,912





















    Property, plant, and equipment, net





    80,445







    88,801



    Pre-publication costs, net





    150,652







    202,820



    Goodwill





    437,977







    437,977



    Other intangible assets, net





    360,290







    402,484



    Operating lease assets





    110,572







    126,850



    Deferred income taxes





    4,997







    2,415



    Deferred commissions





    35,083







    30,659



    Other assets





    34,830







    34,208



    Total assets



    $

    1,974,280





    $

    2,021,126



    Liabilities and Stockholders' Equity

















    Current liabilities

















    Current portion of long-term debt



    $

    —





    $

    19,000



    Accounts payable





    37,449







    38,751



    Royalties payable





    45,166







    34,765



    Salaries, wages, and commissions payable





    41,253







    21,723



    Deferred revenue





    357,864







    342,605



    Interest payable





    11,235







    11,017



    Severance and other charges





    405







    19,590



    Accrued pension benefits





    185







    1,593



    Accrued postretirement benefits





    1,618







    1,555



    Operating lease liabilities





    7,539







    9,669



    Other liabilities





    43,297







    22,912



    Liabilities of discontinued operations





    —







    30,662



    Total current liabilities





    546,011







    553,842





















    Long-term debt, net of discount and issuance costs





    317,579







    624,692



    Operating lease liabilities





    127,426







    132,014



    Long-term deferred revenue





    606,811







    562,679



    Accrued pension benefits





    8,484







    24,061



    Accrued postretirement benefits





    15,940







    16,566



    Deferred income taxes





    21,393







    16,411



    Other liabilities





    212







    398



    Total liabilities





    1,643,856







    1,930,663



    Commitments and contingencies

















    Stockholders' equity

















    Preferred stock, $0.01 par value: 20,000,000 shares authorized; no shares issued and outstanding at December 31, 2021 and 2020





    —







    —



    Common stock, $0.01 par value: 380,000,000 shares authorized; 152,267,951 and 150,459,034 shares issued at December 31, 2021 and 2020, respectively; 127,690,917 and 125,882,000 shares outstanding at December 31, 2021 and 2020, respectively





    1,523







    1,505



    Treasury stock, 24,577,034 shares as of December 31, 2021 and 2020, respectively, at cost





    (518,030)







    (518,030)



    Capital in excess of par value





    4,931,357







    4,918,542



    Accumulated deficit





    (4,042,252)







    (4,255,830)



    Accumulated other comprehensive loss





    (42,174)







    (55,724)



    Total stockholders' equity





    330,424







    90,463



    Total liabilities and stockholders' equity



    $

    1,974,280





    $

    2,021,126



     

     

    Houghton Mifflin Harcourt Company

    Consolidated Statements of Operations







    (Unaudited)

    Three Months Ended

    December 31,





    Years Ended December 31,



    (in thousands of dollars, except share and per share information)



    2021





    2020





    2021





    2020



    Net sales



    $

    178,805





    $

    141,167





    $

    1,050,802





    $

    840,454



    Costs and expenses

































    Cost of sales, excluding publishing rights and pre-publication

       amortization





    63,316







    60,235







    398,706







    370,586



    Publishing rights amortization





    2,517







    3,468







    10,688







    14,800



    Pre-publication amortization





    29,444







    32,047







    108,621







    125,838



    Cost of sales





    95,277







    95,750







    518,015







    511,224



    Selling and administrative





    106,707







    102,540







    445,660







    442,355



    Other intangible assets amortization





    7,241







    6,349







    30,257







    23,917



    Impairment charge for goodwill





    —







    17,000







    —







    279,000



    Restructuring/severance and other charges





    2,469







    98







    12,349







    31,874



    Gain on sale of assets





    —







    —







    (3,661)







    —



    Operating (loss) income





    (32,889)







    (80,570)







    48,182







    (447,916)



    Other income (expense)

































    Retirement benefits non-service income (expense)





    117







    (1,039)







    105







    (856)



    Interest expense





    (8,210)







    (8,753)







    (34,998)







    (37,931)



    Interest income





    25







    26







    77







    899



    Change in fair value of derivative instruments





    (306)







    500







    (1,221)







    672



    Gain on investments





    —







    353







    1,442







    2,091



    Income from transition services agreement





    1,411







    —







    3,664







    —



    Loss on extinguishment of debt





    —







    —







    (12,505)







    —



    (Loss) income from continuing operations before taxes





    (39,852)







    (89,483)







    4,746







    (483,041)



    Income tax expense (benefit) for continuing operations





    6,577







    (1,141)







    2,686







    (12,351)



    (Loss) income from continuing operations





    (46,429)







    (88,342)







    2,060







    (470,690)



    Income (loss) from discontinued operations, net of tax





    —







    5,197







    (1,005)







    (9,148)



    (Loss) gain on sale of discontinued operations, net of tax





    (1,997)







    —







    212,523







    —



    (Loss) income from discontinued operations, net of tax





    (1,997)







    5,197







    211,518







    (9,148)



    Net (loss) income



    $

    (48,426)





    $

    (83,145)





    $

    213,578





    $

    (479,838)



    Net (loss) income per share attributable to common stockholders

































    Basic:

































           Continuing operations



    $

    (0.36)





    $

    (0.70)





    $

    0.02





    $

    (3.75)



           Discontinued operations





    (0.02)







    0.04







    1.66







    (0.07)



           Net (loss) income



    $

    (0.38)





    $

    (0.66)





    $

    1.68





    $

    (3.82)



    Diluted:

































           Continuing operations



    $

    (0.36)





    $

    (0.70)





    $

    0.02





    $

    (3.75)



           Discontinued operations





    (0.02)







    0.04







    1.61







    (0.07)



           Net (loss) income



    $

    (0.38)





    $

    (0.66)





    $

    1.63





    $

    (3.82)



    Weighted average shares outstanding

































    Basic





    127,686,147







    125,867,093







    127,337,815







    125,455,487



    Diluted





    127,686,147







    125,867,093







    131,402,866







    125,455,487



     

     

    Houghton Mifflin Harcourt Company

    Consolidated Statements of Cash Flows







    Years Ended December 31,



    (in thousands of dollars)



    2021





    2020



    Cash flows from operating activities

















    Net income (loss)



    $

    213,578





    $

    (479,838)



    Adjustments to reconcile net income (loss) to net cash provided by operating activities

















    Loss from discontinued operations, net of tax





    1,005







    9,148



    Gain on sale of discontinued operations, net of tax





    (212,523)







    —



    Gain on sale of assets





    (3,661)







    —



    Depreciation and amortization expense





    194,433







    214,429



    Operating lease assets, amortization and impairments





    16,249







    5,397



    Amortization of debt discount and deferred financing costs





    2,705







    2,636



    Gain on investments





    (1,942)







    (2,091)



    Deferred income taxes





    2,400







    (14,355)



    Stock-based compensation expense





    12,217







    11,160



    Write-off of property, plant, and equipment





    1,606







    —



    Loss on extinguishment of debt





    12,505







    —



    Impairment charge for goodwill





    —







    279,000



    Change in fair value of derivative instruments





    1,221







    (672)



    Changes in operating assets and liabilities, net of acquisitions

















    Accounts receivable





    (28,928)







    32,369



    Inventories





    28,083







    42,936



    Other assets





    (28,895)







    (4,860)



    Accounts payable and accrued expenses





    18,788







    (34,039)



    Royalties payable and author advances, net





    13,247







    (18,095)



    Deferred revenue





    59,391







    57,178



    Interest payable





    218







    7,191



    Severance and other charges





    (19,185)







    7,183



    Accrued pension and postretirement benefits





    (2,946)







    3,443



    Operating lease liabilities





    (6,687)







    (1,996)



    Other liabilities





    (9,090)







    (9,639)



    Net cash provided by operating activities - continuing operations





    263,789







    106,485



    Net cash provided by operating activities - discontinued operations





    3,880







    8,763



    Net cash provided by operating activities





    267,669







    115,248



    Cash flows from investing activities

















    Additions to pre-publication costs





    (56,210)







    (60,872)



    Additions to property, plant, and equipment





    (39,093)







    (50,940)



    Proceeds from sale of business





    340,593







    —



    Proceeds from sale of assets





    5,000







    —



    Net cash provided by (used in) investing activities - continuing operations





    250,290







    (111,812)



    Net cash used in investing activities - discontinued operations





    (647)







    (459)



    Net cash provided by (used in) investing activities





    249,643







    (112,271)



    Cash flows from financing activities

















    Borrowings under revolving credit facility





    —







    150,000



    Payments of revolving credit facility





    —







    (150,000)



    Payments of long-term debt





    (342,031)







    (19,000)



    Tax withholding payments related to net share settlements of restricted stock units





    —







    (48)



    Issuance of common stock under employee stock purchase plan





    410







    918



    Net collections under transition services agreement





    6,240







    —



    Net cash used in financing activities - continuing operations





    (335,381)







    (18,130)



    Net increase (decrease) in cash and cash equivalents





    181,931







    (15,153)



    Cash and cash equivalents at beginning of the period





    281,200







    296,353



    Cash and cash equivalents at end of the period



    $

    463,131





    $

    281,200



     

     

    Houghton Mifflin Harcourt Company

    Non-GAAP Reconciliations (Unaudited)



    Adjusted EBITDA 1 



    (in thousands of dollars)







    Three Months Ended December 31,





    Years Ended December 31,







    2021





    2020





    2021





    2020



    Net (loss) income from continuing operations



    $

    (46,429)





    $

    (88,342)





    $

    2,060





    $

    (470,690)



    Interest expense





    8,210







    8,753







    34,998







    37,931



    Interest income





    (25)







    (26)







    (77)







    (899)



    Provision (benefit) for income taxes





    6,577







    (1,247)







    2,686







    (12,457)



    Depreciation expense





    10,533







    12,492







    44,867







    49,874



    Amortization expense





    39,202







    41,864







    149,566







    164,555



    Non-cash charges—goodwill impairment





    —







    17,000







    —







    279,000



    Non-cash charges—stock-compensation





    3,490







    2,865







    12,217







    11,160



    Non-cash charges— (gain) loss on derivative instruments





    306







    (500)







    1,221







    (672)



    Fees, expenses or charges for equity offerings,

       debt or acquisitions/dispositions





    29







    714







    895







    1,080



    Gain on investments





    (500)







    (353)







    (1,942)







    (2,091)



    Gain on sale of assets





    —







    —







    (3,661)







    —



    Loss on extinguishment of debt





    —







    —







    12,505







    —



    Legal settlement





    —







    —







    2,470







    —



    Restructuring/severance and other charges





    2,469







    98







    12,349







    31,874



    Adjusted EBITDA from continuing operations



    $

    23,862





    $

    (6,682)





    $

    270,154





    $

    88,665





    Free Cash Flow 1



    (in thousands of dollars)







    Three Months Ended December 31,





    Years Ended December 31,







    2021





    2020





    2021





    2020



    Cash flows from operating activities

































    Net cash provided by operating activities



    $

    71,092





    $

    40,468





    $

    263,789





    $

    106,485



    Cash flows from investing activities

































    Additions to pre-publication costs





    (14,106)







    (9,953)







    (56,210)







    (60,872)



    Additions to property, plant, and equipment





    (10,421)







    (15,665)







    (39,093)







    (50,940)



    Free Cash Flow



    $

    46,565





    $

    14,850





    $

    168,486





    $

    (5,327)







    1

    All amounts have been adjusted to eliminate the impact of the HMH Books & Media business which has been removed from continuing operations and classified as discontinued operations.

     

    Houghton Mifflin Harcourt Company

    Calculation of Billings (Unaudited)



    Billings 1



    (in thousands of dollars)







    Three Months Ended

    December 31,





    Years Ended

    December 31,







    2021





    2020





    2021





    2020



    Net sales



    $

    178,805





    $

    141,167





    $

    1,050,802





    $

    840,454



    Change in deferred revenue





    (46,709)







    (48,169)







    59,391







    58,178



    Billings



    $

    132,096





    $

    92,998





    $

    1,110,193





    $

    898,632





    Billings is an operating measure utilized by the Company derived as shown above.



    1

    All amounts have been adjusted to eliminate the impact of the HMH Books & Media business which has been removed from continuing operations and classified as discontinued operations.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hmh-announces-fourth-quarter-and-full-year-2021-results-301489154.html

    SOURCE Houghton Mifflin Harcourt

    Get the next $HMHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HMHC

    DatePrice TargetRatingAnalyst
    2/25/2022$20.00 → $21.00Outperform → Market Perform
    BMO Capital
    2/24/2022$19.00Outperform → Market Perform
    BMO Capital Markets
    1/11/2022$19.00 → $20.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $HMHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HMH Unveils Major Platform Enhancements to Empower Educators and Engage Students Heading Back-to-School Nationwide

      Integrations with Google Classroom and Clever, new Spanish-language resources, personalized professional development and more provide streamlined experience, support positive outcomes BOSTON, Aug. 30, 2022 /PRNewswire/ -- Aug. 30, 2022 – As students and teachers nationwide head back to school, learning technology company HMH today announced major enhancements to Ed, HMH's connected teaching and learning platform, that will offer an even more streamlined experience to empower educators and engage students. Seamless integrations with Google Classroom and Clever, as well as refinements and new features to many of HMH's core, supplemental and intervention solutions and professional learning serv

      8/30/22 12:00:00 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • New Research Shows Declining Confidence in the Education Profession, With Educators Calling for Connection, Community and Customization

      Critical insights reveal how edtech is transforming the classroom; 81% of educators say we are now closer to fully realizing the potential of technology in teaching BOSTON, Aug. 18, 2022 /PRNewswire/ -- According to the 2022 Educator Confidence Report, released today from learning technology company HMH, confidence in the education profession has dropped for the second year in a row. An annual barometer for how educators across the country are feeling about the state of teaching and learning, today's report found more than 3 in 4 (76%) educators feel negatively about the state of the teaching profession in the U.S. The Educator Confidence Index, a measure of overall confidence (out of 100),

      8/18/22 10:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • HMH Introduces Connected Foundational Skills Solution Combining Explicit Phonics Instruction and 1:1 AI-driven Tutoring

      HMH's connected teaching and learning approach brings together best of all worlds with Amira Learning + Saxon Phonics & Spelling, providing research-backed foundational reading support for youngest learners BOSTON, Aug. 4, 2022 /PRNewswire/ -- Learning technology company HMH today announced a new connected teaching and learning solution featuring Amira Learning® + Saxon Phonics & Spelling®, to support foundational literacy in K-2 classrooms. Rooted in science of reading research and backed by ESSA-strong evidence bases, this joint solution is designed to complement a comprehensive language arts program with a dynamic mix of print and digital resources that connect explicit, systematic phonic

      8/4/22 9:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Mckernan John R Jr returned 30,429 shares to the company, closing all direct ownership in the company

      4 - Houghton Mifflin Harcourt Co (0001580156) (Issuer)

      4/11/22 6:07:02 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form 4: Oneill James P. returned 132,921 shares to the company, closing all direct ownership in the company to satisfy withholding obligation

      4 - Houghton Mifflin Harcourt Co (0001580156) (Issuer)

      4/11/22 6:05:24 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form 4: Greenthal Jill A returned 60,053 shares to the company, closing all direct ownership in the company

      4 - Houghton Mifflin Harcourt Co (0001580156) (Issuer)

      4/11/22 6:05:04 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Houghton Mifflin Harcourt downgraded by BMO Capital with a new price target

      BMO Capital downgraded Houghton Mifflin Harcourt from Outperform to Market Perform and set a new price target of $21.00 from $20.00 previously

      2/25/22 6:08:19 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Houghton Mifflin Harcourt downgraded by BMO Capital Markets with a new price target

      BMO Capital Markets downgraded Houghton Mifflin Harcourt from Outperform to Market Perform and set a new price target of $19.00

      2/24/22 9:46:25 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Houghton Mifflin Harcourt upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Houghton Mifflin Harcourt from Market Perform to Outperform and set a new price target of $20.00 from $19.00 previously

      1/11/22 7:24:59 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Houghton Mifflin Harcourt Company

      SC 13G - Houghton Mifflin Harcourt Co (0001580156) (Subject)

      4/18/22 5:18:22 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13G/A filed by Houghton Mifflin Harcourt Company (Amendment)

      SC 13G/A - Houghton Mifflin Harcourt Co (0001580156) (Subject)

      4/11/22 8:51:33 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13G/A filed by Houghton Mifflin Harcourt Company (Amendment)

      SC 13G/A - Houghton Mifflin Harcourt Co (0001580156) (Subject)

      2/14/22 2:56:32 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Financials

    Live finance-specific insights

    See more
    • Significant Shareholder Prasad Phatak Sends Letter to Houghton Mifflin Harcourt Company Board of Directors Opposing Veritas Capital Transaction

      Believes Proposed Veritas Tender Offer Significantly Undervalues Company and Deprives Shareholders of Potential Upside under HMHC's Highly Experienced Management Team Does Not Intend to Tender Shares and Urges HMHC to Alternative Options Including Remaining Standalone Public Company Prasad Phatak, a significant shareholder of Houghton Mifflin Harcourt Company ("Houghton Mifflin" or the "Company") (NASDAQ:HMHC) today issued the following letter to the Company's Board of Directors (the "Board"). March 7, 2022 Board of Directors Houghton Mifflin c/o Corporate Secretary 125 High Street Boston, MA 02110 Dear Board Members, I am a shareholder of Houghton Mifflin Harcourt Company ("Houghton

      3/7/22 8:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Laughing Water Capital Issues Public Letter to Board and Employees of Houghton Mifflin Harcourt

      Believes Veritas Capital's $21 per Share Offer Price Significantly Undervalues the Company and Questions the Timing of the Proposed Transaction Announces Intention Not to Tender its Shares and Encourages Employees to Review the Facts Before Making a Decision ROCKVILLE CENTRE, N.Y., March 01, 2022 (GLOBE NEWSWIRE) -- Laughing Water Capital, LP (together with its affiliates, "LWC"), a value focused investment firm that specializes in businesses undergoing transformational change, today issued a letter to the Board of Directors and employees of Houghton Mifflin Harcourt Company (NASDAQ:HMHC) (the "Company"). In the letter, LWC explains why it will NOT be tendering its shares into Veritas Ca

      3/1/22 8:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • HMH Announces Fourth Quarter and Full Year 2021 Results

      BOSTON, Feb. 24, 2022 /PRNewswire/ -- HMH (NASDAQ:HMHC), a learning technology company, announced financial results for the fourth quarter and full year ended December 31, 2021. Q4 and Full Year 2021 Financial Results: Three Months Ended December 31, Years Ended December 31, (in millions of dollars) 2021 1 2020 1 Change 2021 1 2020 1 Change Net sales $ 179 $ 141 26.7 % $ 1,051 $ 840 25.0 % Change in deferred revenue (47) (48) (3.0) % 59 58 2.1 % Billings 2 132 93 42.0 % 1,110 899 23.5 % Impairment charge for goodwill — 17 NM — 279 NM (Loss) income from continuing operations (4

      2/24/22 7:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    SEC Filings

    See more
    • SEC Form 15-12B filed by Houghton Mifflin Harcourt Company

      15-12B - Houghton Mifflin Harcourt Co (0001580156) (Filer)

      4/21/22 2:30:59 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form EFFECT filed by Houghton Mifflin Harcourt Company

      EFFECT - Houghton Mifflin Harcourt Co (0001580156) (Filer)

      4/15/22 12:15:16 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form POS AM filed by Houghton Mifflin Harcourt Company

      POS AM - Houghton Mifflin Harcourt Co (0001580156) (Filer)

      4/12/22 9:28:30 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Leadership Updates

    Live Leadership Updates

    See more
    • HMH Appoints Benita Flucker as Chief Equity and Inclusion Officer

      Flucker will focus on equity in curriculum, solutions and services and serve as strategic advisor for HMH employee resource groups BOSTON, July 26, 2022 /PRNewswire/ -- Learning technology company HMH today announced the appointment of Benita Flucker as Chief Equity and Inclusion Officer. In this critical new position, Flucker will oversee HMH's multifaceted commitment to building and delivering curriculum solutions and services that foster a holistic understanding of the world and honor the diverse students, educators and communities HMH serves each day. Working closely with HMH's Chief People Officer Alejandro Reyes, who will continue to lead HMH's employee-focused diversity, equity and in

      7/26/22 11:30:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • ICLE Appoints Dr. Joshua P. Starr as Managing Partner, Concludes Successful Gathering of Thousands of Educators at 30th Annual Model Schools Conference

      REXFORD, N.Y., July 21, 2022 /PRNewswire/ -- The International Center for Leadership in Education (ICLE), a division of learning technology company HMH, today announced that celebrated education leader Dr. Joshua P. Starr has been appointed as Managing Partner. ICLE, one of the nation's leading education consultancies, researches and disseminates best practices for district-wide achievement and is known for its high-impact work around school transformation. In this critical leadership role, Dr. Starr will oversee the organization's strategic direction, working hand-in-hand with ICLE's partners, consultants and fellows in service of creating impactful change and growth for students and teache

      7/21/22 3:12:00 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Houghton Mifflin Harcourt Appoints Chris Symanoskie as Vice President of Investor Relations

      BOSTON, July 20, 2021 /PRNewswire/ -- Learning technology company Houghton Mifflin Harcourt (HMH) (NASDAQ:HMHC) announced that Chris Symanoskie, IRC has joined the company as Vice President, Investor Relations. In this role, he will serve as the primary liaison between HMH and the financial community and report directly to Chief Financial Officer Joe Abbott. Symanoskie brings over 20 years of investor relations experience with an extensive background in the education services sector. Prior to joining HMH, he served as Vice President of Investor Relations and Corporate Communic

      7/20/21 9:15:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous